NCT05147233已完成3 期
A Randomized, Double-masked, Vehicle-controlled Study Evaluating the Efficacy and Safety of OCS-01 Eyedrops Compared to Vehicle in the Treatment of Inflammation and Pain Following Cataract Surgery
干预措施
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- Oculis
- 入组人数
- 241
- 试验地点
- 25
- 主要终点
- Absence of Anterior Chamber Cells at Visit 6.
研究概览
简要总结
This was a randomized, double-masked, vehicle-controlled, Phase 3 study evaluating the efficacy and safety of OCS-01 QD compared to vehicle in the treatment of inflammation and pain following cataract surgery.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double (Participant, Investigator)
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Be planning to undergo unilateral cataract extraction via phacoemulsification and posterior chamber intraocular lens (PCIOL) implantation in the study eye.
- •Have a pin-hole visual acuity (VA) without any other correction > 20 letters (approximately 20/400) in the operative eye and > 35 letters (approximately 20/200) in the fellow eye as measured using an Early Treatment for Diabetic Retinopathy Study (ETDRS) chart at Visit 1 (Day -1 to Day -28 [prior to surgery]).
排除标准
- •Have any intraocular inflammation (e.g. white blood cells or flare) present in either eye at the Visit 1 (Day -1 to Day -28 [prior to surgery]) slit lamp examination.
- •Have a score > 0 on the Ocular Pain Assessment at Visit 1 (Day -1 to Day -28 [prior to surgery]) in the study eye.
研究组 & 干预措施
Vehicle
Placebo Comparator
1 drop of vehicle in the study eye QD for 14 days, beginning 1-day post-surgery in the study eye.
干预措施: Vehicle (Drug)
OCS-01
Experimental
1 drop of OCS-01 (Dexamethasone ophthalmic suspension 1.5% [15 mg/mL]) in the study eye once daily (QD) for 14 days, beginning 1-day post-surgery in the study eye.
干预措施: OCS-01 (Drug)
结局指标
主要结局
Absence of Anterior Chamber Cells at Visit 6.
时间窗: Day 15
Absence of Ocular Pain at Visit 4.
时间窗: Day 4
次要结局
未报告次要终点
研究者
研究点 (25)
Loading locations...
相似试验
已完成
3 期
Safety and Efficacy of KPI-121 in Subjects With Postsurgical InflammationOcular Infections, Irritations and InflammationsNCT02163824Kala Pharmaceuticals, Inc.380
已完成
3 期
Safety and Efficacy of KPI-121 in Subjects With Postsurgical Inflammation and PainPost Surgical Ocular Inflammation and PainNCT02793817Kala Pharmaceuticals, Inc.520
终止
2 期
A Study Assessing Efficacy and Safety of OC-10X in the Treatment of PDRProliferative Diabetic Retinopathy (PDR)NCT02735369OcuCure Therapeutics, Inc.40
已完成
3 期
Confirmatory Study of OPC-12759 Ophthalmic SuspensionDry Eye SyndromesNCT00885079Otsuka Pharmaceutical Co., Ltd.188
已完成
2 期
Exploratory Study of OPC-12759 Ophthalmic SuspensionKeratoconjunctival Epithelial DisorderNCT01493180Otsuka Pharmaceutical Co., Ltd.102